Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 26, 2017
Pharmacy Choice - News - Front Page Healthcare News - March 26, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/31/16 - Castle Creek Pharmaceuticals Announces License of Exclusive U.S. Rights for Arlevert from Hennig Arzneimittel GmbH
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Castle Creek Pharmaceuticals, LLC, a global company dedicated to delivering transformative therapies to patients with dermatologic and head/neck orphan diseases and underserved conditions, announced completion of an exclusive license agreement for all U.S. rights to Arlevert
12/31/16 - Ebola vaccine shows promise An experimental vaccine against Ebola is 100 percent effective in clinical trials
LOS ANGELES Wednesday AHF lauded the publication of clinical trial results in the journal Lancet which showed 100 percent efficacy in preventing Ebola virus infection among study participants who received an experimental vaccine in Sierra Leone and Guinea. Every year the world collectively spends almost $2 trillion on defense and only $36 billio
12/31/16 - FDA Releases Final Guidance on Postmarket Mgmt of Medical Device Cybersecurity [Seven Days (United Arab Emirates)]
The FDA issued an earlier set of recommendations in October 2014, which recommended ways for manufacturers to build cybersecurity protections into medical devices as they`re being designed and developed. The FDA recommends manufacturers continually monitor cybersecurity vulnerabilities of devices and should create a program to mitigate these risks.
12/31/16 - Future of health care unclear as fate of Obamacare hangs in the balance [St. Louis Post-Dispatch]
Dec. 31 The Affordable Care Act President Barack Obama's landmark health reform bill took some hits in 2016, but it could be in for a real beatdown this year. It's unclear what will become of the Affordable Care Act under a Donald Trump presidency. "It was a difficult year because of the departures by insurers," said Paul Ginsburg, director
12/31/16 - Global Blood Pressure Monitoring Device Market will reach USD 3.25 Billion by 2021: Zion Market Research [Jerusalem Post (Israel)]
-Zion Research has published a new report Titled Blood Pressure Monitoring Device Market by Device Type and by Accessory Type for Hospitals, Homecare, Diagnostics Laboratory and Others Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 2021. According to the report, the globalblood pressure monitoring device marketaccounted for.
12/31/16 - Global Outpatient Care Centers Market Briefing 2017 - Research and Markets
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Outpatient Care Centers Global Market Briefing 2017" report to their offering. The Outpatient Care Centers Global Market Briefing provides strategists, marketers and senior management with the critical information they need to as
12/31/16 - Government to reduce prices of surgical equipment [Moj News Agency (Iran)]
Sri Lanka`s Minister of Health Dr. Rajitha Senaratne has decided to reduce the prices of surgical equipment, coinciding with the move to slash the prices of essential medicinal drugs. Minister Rajitha Senaratne has given instructions to the National Drugs Regulatory Authority to draft a proper mechanism to reduce the prices of surgical equipment.
12/31/16 - Humacyte Commences U.S. Phase II Arterial Bypass Clinical Trial [Saudi Press Agency (Saudi Arabia)]
Humacyte, an innovator in biotechnology and regenerative medicine, announced today the initiation of a U.S. Phase II arterial bypass clinical trial of HUMACYL, its investigational human acellular vessel, to test the safety and efficacy as a lower extremity arterial bypass vessel in patients with peripheral arterial disease. The initiation of the Ph
Pharmaceutical company Lupin has received tentative approval from the United States Food and Drug Administration to market its cholesterol lowering Pitavastatin tablets in the American market. has received approval for Pitavastatin tablets in the strength of 1 milligram, 2 mg and 4 mg. Pitavastatin is a generic version of Kowa's Livalo tablets in t
12/31/16 - Medical Power Supply Devices Market Poised to Account for US$ 1,613.9 Million by 2022 [Cihan News Agency (Turkey)]
The medical power supply devices market is estimated to be valued at US$ 1,263.3 Mn by the end of 2016 and is anticipated to expand at a CAGR of 4.5% from 2016 to 2022, to account for US$ 1,613.9 Mn by 2022.. Power supply devices, also known as electric power converters, are electronic devices that convert one form of electrical energy into another
12/31/16 - NCH Healthcare to acquire NDIC, combine it with radiology offices to form NCH Imaging [Naples Daily News, Fla.]
Its three diagnostic imaging centers in the Naples area will be acquired by the NCH Healthcare System, effective Jan. 1. All of the centers will remain open and will be combined with NCH's existing outpatient radiology offices to create NCH Imaging, said Debbie Curry, a spokeswoman for NCH, in an email. NDIC has operated as an NCH affiliate, with r
12/31/16 - Neurotrophic Keratitis: EMA Validates the Marketing Authorisation Application for Cenegermin Eye Drops Oxervate Submitted by Dompe
By a News Reporter-Staff News Editor at Marketing Weekly News The biopharmaceutical company Dompe announced the acceptance of the registration application submitted to the European Medicines Agency for Oxervate eye drops, for the treatment of moderate and severe neurotrophic keratitis in adult patients. Acceptance by EMA constitutes the...
12/31/16 - Obama's last month: 'Obamacare' defense, Chicago speech
HONOLULU Eager to stop Republicans from destroying his signature health care law, President Barack Obama and Democratic lawmakers will meet next week to try to forge a common strategy. The White House is casting it as an effort to unite Democrats behind a plan to protect the law, known as the Affordable Care Act, before Republicans have a chance to
12/31/16 - Pharmacist: New medications help with dry eyes, seizures and hallucinations
In 2016, many new and useful medications got FDA approval. My articles are syndicated worldwide, but I'm only listing English drug names so please ask your local pharmacist to translate the medication name for your country. So the FDA approved this injectable drug to help people who have been exposed from infected animals, contaimated animal produc
12/31/16 - Toxic Beauty: Bed, bath and way beyond
Heavy Metal and makeup have more in common than you might know. Lipsticks, mascara, sunblock, and deodorant are just a few of the toxic products that contain levels of heavy metals and other substances that are unregulated by the FDA. Unlike drug companies, cosmetics companies may use almost any ingredients they choose, with few exceptions.
12/30/16 - "Cosmetic and Pharmaceutical Foam" in Patent Application Approval Process (USPTO 20160354473)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Tamarkin, Dov; Friedman, Doron; Eini, Meir, filed on August 16, 2016, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a co
12/30/16 - "Dose Titration Aid" in Patent Application Approval Process (USPTO 20160354536)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Radmer, Bo, filed on February 23, 2015, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Novo Nordisk A/S. The following quote was obt
12/30/16 - "Medical Device Notification System" in Patent Application Approval Process (USPTO 20160354562)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventor Morrison, Mark Steven, filed on June 3, 2016, was made available online on December 15, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Microdose Therapeutx, Inc.. The followi
12/30/16 - 18 Stocks Moving In Friday's Pre-Market Session
Gainers Marinus Pharmaceuticals Inc rose 29.3 percent to $1.080 in pre-market trading as the company disclosed that ganaxolone has received Orphan Drug designation for the treatment of Fragile X Syndrome. China Cord Blood Corp shares rose 16.1 percent to $6.35 in pre-market trading after Golden Meditech agreed to sell its equity interest in China C
12/30/16 - Ab Initio Announces Strategic Collaboration with Pfizer to Discover GPCR Activating Antibodies
By a News Reporter-Staff News Editor at Drug Week Ab Initio Biotherapeutics, Inc., announced a collaborative research and license agreement with Pfizer Inc. that aims to discover novel therapeutic antibodies against an undisclosed target in the G-protein coupled receptor superfamily. Pfizer has exclusive worldwide rights to develop and commercial
12/30/16 - Abbott Acquisition of St. Jude Medical Set to Close on January 4, 2017
ABBOTT PARK, Illinois, Dec. 30, 2016/ PRNewswire/ Abbott announced today it intends to close the acquisition of St. Jude Medical, Inc., on Wednesday, Jan. 4, 2017. "We continue to deliberately shape our business for long-term success by securing leadership positions in attractive markets and focusing on customer needs," said Miles D. White, chai
12/30/16 - Abbott Labs says it plans to wrap up St. Jude Medical deal Jan. 4 [Star Tribune (Minneapolis)]
Dec. 30 Abbott Laboratories intends to close its deal to buy medical device maker St. Jude Medical just after the new year, now that it has received permission from U.S. and international antitrust regulators scrutinizing the $25 billion deal. Abbott Labs, based in suburban Chicago, said Friday it intends to close the deal on Jan. 4; originally,
12/30/16 - Abbott to Sell 2 Medical Device Businesses for St. Jude Buyout [Daily News Egypt]
Shares of Abbott Labs underperformed the Zacks classified Large Cap Pharmaceuticals industry in the year-to-date period. Coming back to the latest news, the divestment will ensure fair competition in the U.S. markets for medical devices used in cardiac and vascular catheterization. Note that the FTC had alleged that the proposed acquisition would i
12/30/16 - Acerus Announces NATESTO License Agreement with Hyundai Pharm
By a News Reporter-Staff News Editor at Health& Medicine Week Acerus Pharmaceuticals Corporation announced the signing of an agreement granting the exclusive right to market NATESTO in South Korea to Hyundai Pharm Co., LTD., a South Korean pharmaceutical company. "Hyundai has a proven track record of success in launching products, building ne
12/30/16 - Agency highlights 2016
The Medicines and Healthcare products Regulatory Agency is focussed on protecting and promoting public health through its three centres: Clinical Practice Research Datalink, National Institute for Biological Standards and Control and MHRA. The number of first in human clinical trials carried out in the UK is also increasing. This is significant as
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement